Helicobacter pylori et anti-inflammatoires non stéroïdiens Helicobacter pylori et reflux gastro-œsophagien - Helicobacter pylori and NSAID. Helicobacter pylori in GORD
Zerbib, F.
Hepato-Gastro (Montrouge) 5(FEV): 56-60
1998
ISSN/ISBN: 1253-7020 Document Number: 233479
Document emailed within 1 workday
Related Documents
Shimamoto, C.; Tokioka, S.; Hirata, I.; Tani, H.; Ohishi, H.; Katsu, K-ichi. 2002: Inhibition of Helicobacter pylori infection by orally administered yolk-derived anti-Helicobacter pylori antibody Hepato-Gastroenterology 49(45): 709-714Koizumi, W.; Tanabe, S.; Imaizumi, H.; Hibi, K-ichi.; Kida, M.; Ohida, M.; Okayasu, I.; Saigenji, K. 2003: Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection Hepato-Gastroenterology 50(49): 293-296
Gaidar, I.A.; Stepanova, E.V.; Mosiichuk, L.N.; Demeshkina, L.V.; Sheikhetova, G.A.; Bespalova, E.V.; Kudriavtseva, V.E.; Vcherashniaia, N.N. 2001: Particular features of the relationship of Helicobacter pylori and G cells in patients with duodenal ulcer, with special reference to the Helicobacter pylori strain Likars'ka Sprava 2001(4): 176-177
Lou, J-gan.; Chen, J.; Huang, X-lei.; Zhao, Z-yan. 2007: Changes in the intestinal microflora of children with Helicobacter pylori infection and after Helicobacter pylori eradication therapy Chinese Medical Journal 120(10): 929-931
Katelaris, P.H. 2003: Gastro-oesophageal reflux disease and Helicobacter pylori Minerva Gastroenterologica E Dietologica 49(4): 235-241
Kowalski, M. 2001: Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. the detection of H. pylori specific DNA in human coronary atherosclerotic plaque Journal of Physiology and Pharmacology An Official Journal of the Polish Physiological Society 52(1 Suppl 1): 3-31
Henry, A.; Batey, R.G. 1998: Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect of ten years of H. pylori treatment? Australian and New Zealand Journal of Medicine 28(3): 345
Thong-Ngam, D.; Chayanupatkul, M.; Klaikeaw, N.; Rerknimitr, R.; Mahachai, V. 2009: Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori Journal of the Medical Association of Thailand 92(9): 1207-1212
Russell, R.I. 1997: Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users Italian Journal of Gastroenterology and Hepatology 29(5): 465-469
Yerra, L.N.; Bhasin, D.K.; Panigrahi, D.; Vaiphei, K.; Sharma, B.C.; Ray, P. 1999: Prevalence of Helicobacter pylori infection in patients with reflux oesophagitis Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 20(4): 175-177
Chebib, H.; Artiko, V.; Ugljesić, M.; Petrović, M.; Obradović, V. 1999: The presence and significance of Helicobacter pylori in patients with enterogastric reflux Acta Chirurgica Iugoslavica 46(1-2): 53-56
Feng, G.-j.; Hu, F.-l.; Wang, H.-h.; Liu, J.-x. 2003: A study on the relationship of Helicobacter pylori, gastrin and gastroesophageal reflux disease Zhonghua Yi Xue Za Zhi 83(2): 96-99
Huang, H.; Tian, J.; Xu, X.; Liang, Q.; Huang, X.; Lu, J.; Yao, Y. 2018: A study on the roles of Helicobacter pylori in bile reflux gastritis and gastric cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 23(3): 659-664
Kuipers, E.J.; Klinkenberg-Knol, E.C.; Festen, H.P.; Meuwissen, S.G. 1998: Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole? Nederlands Tijdschrift Voor Geneeskunde 142(16): 883-885
Melichar, B.; Bures, J.; Komarkova, O.; Rejchrt, S.; Fixa, B.; Karlicek, R. 1995: Increased gastric juice nitrate is associated with biliary reflux and Helicobacter pylori infection American Journal of Gastroenterology 90(7): 1190-1191
Caccavo, D.; Leri, O.; Ferri, G.M.; Perinelli, P.; De Luca, D.; Afeltra, A. 1997: Anti-TNF-alpha antibodies are not associated with Helicobacter pylori induced gastritis European Review for Medical and Pharmacological Sciences 1(4): 111-113
García-Díaz, E.; Castro-Fernández, M.; Romero-Gómez, M.; Vargas-Romero, J. 2002: The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 94(12): 725-736
Vasil'ev, I.V.; Nikol'skaia, K.A. 2005: Results of the treatment of duodenal ulcer associated with Helicobacter pylori and combined with gastroesophageal reflux disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 6: 61-64
Tsaregorodtseva, T.M.; Serova, T.I.; Gladilina, M.V.; Gubina, A.V. 2006: Contents of anti-Helicobacter pylori antibodies in digestive system diseases Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 54-58
Zaterka, S. 2001: Anti-secretory agents modify the gastric localization of Helicobacter pylori Arquivos de Gastroenterologia 38(1): 1-2